Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.76% |
| 2 | Financials | 7.62% |
| 3 | Healthcare | 7.1% |
| 4 | Industrials | 5.08% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWLV
2626
DELISTED
Twelve Seas Investment Company II Class A Common Stock
TWLV
| $5.7M | ﹤0.01% |
583,270
+10,159
| +2% | +$99.3K |
|
|
VERV
2627
DELISTED
Verve Therapeutics
VERV
| $5.68M | ﹤0.01% |
+371,671
| New | +$5.76M |
|
2628
Frontline
FRO
$8.81B
| $5.67M | ﹤0.01% |
+640,301
| New | +$5.8M |
|
|
ASPC
2629
DELISTED
Alpha Capital Acquisition Co
ASPC
| $5.67M | ﹤0.01% |
574,207
+65,469
| +13% | +$648K |
|
2630
Archer Aviation
ACHR
$5.11B
| $5.67M | ﹤0.01% |
1,839,471
+1,689,222
| +1,124% | +$6.8M |
|
2631
Valley National Bancorp
VLY
$8.1B
| $5.66M | ﹤0.01% |
543,858
-783,057
| -59% | -$9.3M |
|
2632
Millicom
TIGO
$16B
| $5.66M | ﹤0.01% |
393,912
+334,189
| +560% | +$6.86M |
|
|
NGM
2633
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $5.66M | ﹤0.01% |
441,475
+24,059
| +6% | +$333K |
|
2634
CALL
Fortinet
FTNT
$122B
| $5.66M | ﹤0.01% |
+100,000
| New | +$5.94M |
|
|
APXI
2635
DELISTED
APx Acquisition Corp. I Class A Ordinary Share
APXI
| $5.66M | ﹤0.01% |
565,000
+162,880
| +41% | +$1.63M |
|
|
CGAU
2636
Centerra Gold
CGAU
$4.12B
| $5.65M | ﹤0.01% |
833,765
+260,875
| +46% | +$2.21M |
|
|
MMAT
2637
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $5.65M | ﹤0.01% |
54,883
+54,633
| +21,853% | +$8.15M |
|
2638
iShares US Basic Materials ETF
IYM
$1.02B
| $5.65M | ﹤0.01% |
+48,000
| New | +$6.64M |
|
2639
RPM International
RPM
$14.7B
| $5.65M | ﹤0.01% |
71,746
-255,803
| -78% | -$21.5M |
|
2640
Bausch + Lomb
BLCO
$6B
| $5.64M | ﹤0.01% |
+370,130
| New | +$6M |
|
|
CERE
2641
PUT
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $5.62M | ﹤0.01% |
+212,600
| New | +$6.04M |
|
|
BCYC
2642
Bicycle Therapeutics
BCYC
$290M
| $5.6M | ﹤0.01% |
333,701
+170,334
| +104% | +$3.59M |
|
2643
PUT
Ametek
AME
$58.1B
| $5.58M | ﹤0.01% |
+50,800
| New | +$6.17M |
|
2644
CALL
Antero Resources
AR
$11.1B
| $5.58M | ﹤0.01% |
182,000
+134,000
| +279% | +$4.9M |
|
2645
Prothena Corp
PRTA
$440M
| $5.56M | ﹤0.01% |
204,670
-68,005
| -25% | -$1.99M |
|
2646
AEON Biopharma
AEON
$13.8M
| $5.55M | ﹤0.01% |
7,859
-35
| -0.4% | -$24.7K |
|
2647
CALL
Target
TGT
$67.9B
| $5.55M | ﹤0.01% |
39,300
-254,600
| -87% | -$48.8M |
|
2648
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $5.54M | ﹤0.01% |
54,156
-29,169
| -35% | -$2.99M |
|
2649
Duke Energy
DUK
$95.1B
| $5.54M | ﹤0.01% |
51,642
-711,201
| -93% | -$78.2M |
|
|
AGAC
2650
DELISTED
African Gold Acquisition Corp
AGAC
| $5.54M | ﹤0.01% |
565,360
+41,382
| +8% | +$405K |
|
Similar funds
Millennium Management's Q2 2022 Portfolio in Review
As of Q2 2022, Millennium Management held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Millennium Management's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Millennium Management added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Millennium Management's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Millennium Management fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Millennium Management's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Millennium Management opened 1,144 new positions and closed 1,065 in Q2 2022.
- Millennium Management's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.